332 related articles for article (PubMed ID: 20434203)
1. What targeting eosinophils has taught us about their role in diseases.
Bochner BS; Gleich GJ
J Allergy Clin Immunol; 2010 Jul; 126(1):16-25; quiz 26-7. PubMed ID: 20434203
[TBL] [Abstract][Full Text] [Related]
2. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome.
Kay AB; Klion AD
Immunol Allergy Clin North Am; 2004 Nov; 24(4):645-66, vii. PubMed ID: 15474864
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.
Amini-Vaughan ZJ; Martinez-Moczygemba M; Huston DP
Curr Allergy Asthma Rep; 2012 Oct; 12(5):402-12. PubMed ID: 22875242
[TBL] [Abstract][Full Text] [Related]
4. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma.
Fukuda T; Fukushima Y; Numao T; Ando N; Arima M; Nakajima H; Sagara H; Adachi T; Motojima S; Makino S
Am J Respir Cell Mol Biol; 1996 Jan; 14(1):84-94. PubMed ID: 8534490
[TBL] [Abstract][Full Text] [Related]
5. Role of vascular cell adhesion molecule-1 and platelet-activating factor in selective eosinophil migration across vascular endothelial cells.
Sano H; Nakagawa N; Nakajima H; Yoshida S; Iwamoto I
Int Arch Allergy Immunol; 1995 Aug; 107(4):533-40. PubMed ID: 7542515
[TBL] [Abstract][Full Text] [Related]
6. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
[TBL] [Abstract][Full Text] [Related]
7. VCAM-1 is more effective than MAdCAM-1 in supporting eosinophil rolling under conditions of shear flow.
Sriramarao P; DiScipio RG; Cobb RR; Cybulsky M; Stachnick G; Castaneda D; Elices M; Broide DH
Blood; 2000 Jan; 95(2):592-601. PubMed ID: 10627468
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm.
Wardlaw AJ
J Allergy Clin Immunol; 1999 Nov; 104(5):917-26. PubMed ID: 10550733
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-5 enhances eosinophil adhesion to bronchial epithelial cells.
Sanmugalingham D; De Vries E; Gauntlett R; Symon FA; Bradding P; Wardlaw AJ
Clin Exp Allergy; 2000 Feb; 30(2):255-63. PubMed ID: 10651778
[TBL] [Abstract][Full Text] [Related]
10. [The roles of adhesion molecules, cytokines, and chemokines in eosinophil activation during allergic inflammation].
Chihara J
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():116-20. PubMed ID: 9216199
[TBL] [Abstract][Full Text] [Related]
11. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.
Brooks AM; Bates ME; Vrtis RF; Jarjour NN; Bertics PJ; Sedgwick JB
Am J Respir Cell Mol Biol; 2006 Oct; 35(4):503-11. PubMed ID: 16728704
[TBL] [Abstract][Full Text] [Related]
13. The Eosinophil in Health and Disease: from Bench to Bedside and Back.
Liao W; Long H; Chang CC; Lu Q
Clin Rev Allergy Immunol; 2016 Apr; 50(2):125-39. PubMed ID: 26410377
[TBL] [Abstract][Full Text] [Related]
14. Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases.
Stein ML; Munitz A
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):201-9. PubMed ID: 20807192
[TBL] [Abstract][Full Text] [Related]
15. Degranulation of eosinophils mediated by intercellular adhesion molecule-1 and its ligands is involved in adhesion molecule expression on endothelial cells-selective induction of VCAM-1.
Chihara J; Yamamoto T; Kayaba H; Kakazu T; Kurachi D; Yamamoto J; Iwasa S; Iida K; Urayama O; Kobayashi Y
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S452-6. PubMed ID: 10329848
[TBL] [Abstract][Full Text] [Related]
16. A tribute to eosinophils from a comparative and evolutionary perspective.
Stacy NI; Ackerman SJ
J Allergy Clin Immunol; 2021 Mar; 147(3):1115-1116. PubMed ID: 33451799
[No Abstract] [Full Text] [Related]
17. Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent.
Symon FA; Walsh GM; Watson SR; Wardlaw AJ
J Exp Med; 1994 Jul; 180(1):371-6. PubMed ID: 7516413
[TBL] [Abstract][Full Text] [Related]
19. Verdict in the case of therapies versus eosinophils: the jury is still out.
Bochner BS
J Allergy Clin Immunol; 2004 Jan; 113(1):3-9; quiz 10. PubMed ID: 14713900
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma.
Stirling RG; van Rensen EL; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1403-9. PubMed ID: 11704586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
